**Core Concept**
Anaplastic carcinoma, also known as anaplastic thyroid cancer, is a highly aggressive and malignant form of thyroid cancer. It arises from the follicular epithelial cells of the thyroid gland and is characterized by rapid growth and early metastasis.

**Why the Correct Answer is Right**
Anaplastic carcinoma is associated with mutations in the TP53 gene, which encodes for the tumor suppressor protein p53. The p53 protein plays a crucial role in regulating cell growth, DNA repair, and apoptosis. Mutations in TP53 can lead to the loss of p53 function, resulting in uncontrolled cell growth and tumor formation. The association of anaplastic carcinoma with p53 mutations is well-established and is a key factor in its aggressive behavior. The mutations in TP53 can also lead to the accumulation of other genetic alterations, further contributing to the development and progression of anaplastic carcinoma.

**Why Each Wrong Option is Incorrect**
**Option A:** Anaplastic carcinoma is not common in young individuals. It typically occurs in older adults, with a median age at diagnosis of around 60-70 years. This option is incorrect because anaplastic carcinoma is more common in elderly patients.
**Option C:** The surrounding neck tissue is not usually free in anaplastic carcinoma. In fact, one of the hallmark features of anaplastic carcinoma is its aggressive invasion of surrounding tissues, including the trachea, esophagus, and major blood vessels. This option is incorrect because anaplastic carcinoma is known for its local invasiveness.
**Option D:** Radiotherapy does not cure anaplastic carcinoma. While radiotherapy can provide palliative benefits and improve quality of life, it is not a curative treatment for anaplastic carcinoma. This option is incorrect because anaplastic carcinoma is a highly aggressive and treatment-resistant form of cancer.

**Clinical Pearl / High-Yield Fact**
Anaplastic carcinoma is a rare but highly aggressive form of thyroid cancer, accounting for only 1-2% of all thyroid cancer cases. It is often associated with a poor prognosis, with a median survival time of around 4-6 months from diagnosis.

**✓ Correct Answer: B. Associated with p53 mutation**